ColinAA, ShafieianM, AndreanskyM. Bronchoscopic instillation of activated recombinant factor VII to treat diffuse alveolar hemorrhage in a child. Pediatr Pulmonol, 2010; 45:411.
2.
EstellaA, JarenoA, Perez-Bello FontainaL. Intrapulmonary administration of recombinant activated factor VII in diffuse alveolar haemorrhage: a report of two case stories. Cases J, 2008; 1:150.
3.
HesletL, NielsenJD, LeviM, et al.Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care, 2006; 10:R177.
4.
HesletL, NielsenJD, Nepper-ChristensenS. Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH)—a review of a new treatment paradigm. Biologics, 2012; 6:37–46.
5.
LabattagliaMP, IhleB. Recombinant activated factor VII: current perspectives and Epworth experience. Heart Lung Circ, 2007; 16:S96–101.
6.
MacdonaldJA, FraserJF, FootCL, et al.Successful use of recombinant factor VII in massive hemoptysis due to community-acquired pneumonia. Chest, 2006; 130:577–579.
7.
HenkeD, FalkRJ, GabrielDA. Successful treatment of diffuse alveolar hemorrhage with activated factor VII. Ann Intern Med, 2004; 140:493–494.
8.
PastoresSM, PapadopoulosE, VoigtL, et al.Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: treatment with recombinant factor VIIa. Chest, 2003; 124:2400–2403.
9.
SimpsonE, LinY, StanworthS, et al.Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev, 2012:CD005011.
10.
GrochovaM, KalnasovaB, FirmentJ, et al.Pulmonary administration of activated recombinant factor VII. Bratisl Lek Listy, 2011; 112:29–33.
11.
RoseRM, KobzikL, DushayK, et al.The effect of aerosolized recombinant human granulocyte macrophage colony-stimulating factor on lung leukocytes in nonhuman primates. Am Rev Respir Dis, 1992; 146:1279–1286.
12.
HoffmanM. A cell-based model of coagulation and the role of factor VIIa. Blood Rev, 2003; 17:S1–5.
13.
WeiskopfRB. Recombinant-activated coagulation factor VIIa (NovoSeven): current development. Vox Sang, 2007; 92:281–288.
14.
YilmazD, KarapinarB, BalkanC, et al.Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Pediatr Hematol Oncol, 2008; 25:301–311.
15.
JeffreyA. Alten. Pediatric off-label use of recombinant factor VIIa. J Pediatrics, 2009; 123:1066.
16.
CharM. Witmer. Off-label recombinant factor VIIa use and thrombosis in children: a multicenter cohort study. J Pediatr, 2011; 158:820–825.
